NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the Director's Pioneer Award Program (DP1 Clinical Trial Optional), aimed at supporting individual scientists with exceptional creativity who propose innovative research projects in the biomedical sciences. Applicants are encouraged to present pioneering research that diverges significantly from existing scientific directions, with the potential for substantial impact on areas relevant to NIH's mission. The program has an estimated total funding of $8.1 million, with each award set at $700,000, and anticipates making approximately eight awards. Interested applicants can reach out to the NIH Director's Pioneer Award Program via email at PioneerAwards@mail.nih.gov, with applications due by September 9, 2026, and project start dates expected by September 30, 2026.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government, excluding the NIH Intramural Research Program (NIH IRP);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).